Valuation: Phaarmasia Limited

Market Cap 513M 5.4M 4.68M 4.36M 4.01M 7.57M 7.65M 51.22M 20.1M 257M 20.28M 19.83M 851M P/E 2024
-38.3x
P/E 2025 -12.6x
Enterprise Value 511M 5.38M 4.66M 4.34M 3.99M 7.54M 7.62M 51.03M 20.03M 256M 20.2M 19.76M 848M EV / Sales 2024
0.64x
EV / Sales 2025 0.81x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day+2.09%
1 week-0.02%
Current month-4.14%
1 month-13.94%
3 months-15.02%
6 months-18.00%
Current year-24.62%
1 week 80.75
Extreme 80.75
89
1 month 80.75
Extreme 80.75
103.67
Current year 69
Extreme 69
131.75
1 year 26
Extreme 26
131.75
3 years 23.25
Extreme 23.25
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+2.09%-0.02%+209.02%+244.05% 5.98M
+4.86%-3.32%+52.73%+160.26% 1,043B
+1.04%-2.99%+50.87%+52.38% 621B
+0.98%-6.49%+24.00%+66.66% 435B
+0.43%+3.51%+47.14%+38.12% 361B
+0.77%-1.07%+35.78%+39.59% 293B
-0.51%-6.02%+8.14%+9.81% 251B
+4.57%+5.21%+35.91%+67.64% 220B
+0.97%-10.46%+2.35%-45.70% 201B
-2.58%-0.73%+17.16%+67.46% 164B
Average +0.50%-4.10%+48.31%+70.03% 358.91B
Weighted average by Cap. +0.63%-3.79%+38.38%+76.14%

Financials

2024 2025
Net sales 306M 3.22M 2.79M 2.6M 2.39M 4.51M 4.56M 30.52M 11.98M 153M 12.08M 11.82M 507M 244M 2.56M 2.22M 2.07M 1.9M 3.59M 3.63M 24.31M 9.54M 122M 9.63M 9.41M 404M
Net income -5.18M -54.5K -47.2K -44K -40.47K -76.4K -77.25K -517K -203K -2.59M -205K -200K -8.59M -15.89M -167K -145K -135K -124K -234K -237K -1.59M -622K -7.95M -628K -614K -26.34M
Net Debt -3.43M -36.09K -31.26K -29.14K -26.8K -50.6K -51.16K -342K -134K -1.72M -136K -133K -5.69M -1.94M -20.37K -17.64K -16.45K -15.13K -28.56K -28.88K -193K -75.85K -969K -76.51K -74.82K -3.21M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
36
Date Price Change Volume
06/08/26 84.98 +2.09% 415
05/08/26 ₹83.24 -4.60% 146
04/08/26 ₹87.25 -0.51% 402
03/08/26 ₹87.70 -1.07% 193
31/07/26 ₹88.65 +4.29% 412
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock